Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Human Apolipoprotein E2 Transgenic Mice Show Lipid Accumulation in Retinal Pigment Epithelium and Altered Expression of VEGF and bFGF in the Eyes

  • Lee, Sung-Joon (Division of Food Bioscience and Technology, College of Life Sciences and Biotechnology, Institute of Biomedical Science and Safety, Korea University) ;
  • Kim, Jeong-Hun (Department of Ophthalmology, College of Medicine, Seoul National University & Clinical Research Institute, Seoul National University Hospital) ;
  • Kim, Jin-Hyoung (Division of Pharmaceutical Bioscience, College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University) ;
  • Chung, Mi-Ja (Division of Food Bioscience and Technology, College of Life Sciences and Biotechnology, Institute of Biomedical Science and Safety, Korea University) ;
  • Wen, Qingcheng (Division of Food Bioscience and Technology, College of Life Sciences and Biotechnology, Institute of Biomedical Science and Safety, Korea University) ;
  • Chung, Hum (Department of Ophthalmology, College of Medicine, Seoul National University & Clinical Research Institute, Seoul National University Hospital) ;
  • Kim, Kyu-Won (Division of Pharmaceutical Bioscience, College of Pharmacy and Research Institute of Pharmaceutical Science, Seoul National University) ;
  • Yu, Young-Suk (Department of Ophthalmology, College of Medicine, Seoul National University & Clinical Research Institute, Seoul National University Hospital)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

We investigated the human apolipoprotein E2 (apoE2) transgenic mouse as an animal model system for age-related macular degeneration (AMD). Transgenic mice expressing human apoE2 and C57BL/6J mice were fed normal chow or a high-fat diet for 4 weeks. Eyes were collected from the mice and lipid deposits in retinal pigment epithelium (RPE) were assessed using electron microscopy. The expressions of apoE, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and pigment-epithelium derived factor (PEDF), which are molecular markers for angiogenesis, were assessed with immunohistochemistry. Eyes from apoE2 mice, regardless of diet, contained lipid accumulation in RPE under electron microscopy, whereas control C57BL/6J eyes did not. Lipid accumulation was found predominantly in the RPE and the Bruch's membrane and increased in the eyes of apoE2 mice after one month of a high-fat diet ($8{\pm}2\;per\;50{\mu}m^2$ for normal chow and $11{\pm}2\;per\;50\;{\mu}m^2,\;p<0.05)$. ApoE expression was similar in the apoE2 and control mice; however, VEGF and bFGF were overexpressed in the retinal pigment epithelium of apoE2 eyes compared with control eyes, and PEDF expression was slightly decreased. These expression patterns of VEGF, bFGF, and PEDF suggest angiogenesis is progressing in apoE2 eyes. In conclusion, the eyes of apoE2 mice develop typical lipid accumulations, a common characteristic of AMD, making them a suitable animal model for AMD. The expression profile of VEGF and bFGF on the retinal pigment epithelium suggests that apoE2 may induce neovascularization by altering angiogenic cytokines.

Keywords

References

  1. Algvere, P. V. and S. Seregard. 2003. Drusen maculopathy: A risk factor for AMD. Can we prevent visual loss? Acta Ophthalmol. Scand. 81: 427-429 https://doi.org/10.1034/j.1600-0420.2003.00157.x
  2. Amano, S., S. Yamagishi, Y. Inagaki, K. Nakamura, M. Takeuchi, H. Inoue, and T. Imaizumi. 2005. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvasc. Res. 69: 45-55 https://doi.org/10.1016/j.mvr.2004.11.001
  3. Badimon, J. J., B. A. Kottke, T. C. Chen, L. Chan, and S. J. Mao. 1986. Quantification and immunolocalization of apolipoprotein E in experimental atherosclerosis. Atherosclerosis 61: 57-66 https://doi.org/10.1016/0021-9150(86)90113-9
  4. Bhutto, I. A., D. S. McLeod, T. Hasegawa, S. Y. Kim, C. Merges, P. Tong, and G. A. Lutty. 2006. Pigment epitheliumderived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with agerelated macular degeneration. Exp. Eye Res. 82: 99-110 https://doi.org/10.1016/j.exer.2005.05.007
  5. Browning, A. C., W. M. Amoaku, and H. S. Dua. 2004. Treatment of age-related macular degeneration. J. Soc. Med. 97: 166-169 https://doi.org/10.1258/jrsm.97.4.166
  6. Cooper, A. D. 1997. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38: 2173-2192
  7. Dawson, D. W., O. V. Volpert, P. Gillis, S. E. Crawford, H. Xu, W. Benedict, and N. P. Bouck. 1999. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 285: 245-248 https://doi.org/10.1126/science.285.5425.245
  8. De Jong, P. T. 2004. Risk profiles for ageing macular disease. Ophthalmologica 218 Suppl 1: 5-16; discussion 39-41 https://doi.org/10.1159/000079462
  9. de Knijff, P., A. M. van den Maagdenberg, A. F. Stalenhoef, J. A. Leuven, P. N. Demacker, L. P. Kuyt, R. R. Frants, and L. M. Havekes. 1991. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. J. Clin. Invest. 88: 643-655 https://doi.org/10.1172/JCI115349
  10. de Man, F. H., F. de Beer, A. van de Laarse, A. H. Smelt, J. A. Leuven, and L. M. Havekes. 1998. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase. Atherosclerosis 136: 255-262 https://doi.org/10.1016/S0021-9150(97)00218-9
  11. Duh, E. J., H. S. Yang, I. Suzuma, M. Miyagi, E. Youngman, K. Mori, M. Katai, L. Yan, K. Suzuma, K. West, S. Davarya, P. Tong, P. Gehlbach, J. Pearlman, J. W. Crabb, L. P. Aiello, P. A. Campochiaro, and D. J. Zack. 2002. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 43: 821-829
  12. Gehlbach, P., A. M. Demetriades, S. Yamamoto, T. Deering, E. J. Duh, H. S. Yang, C. Cingolani, H. Lai, L. Wei, and P. A. Campochiaro. 2003. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther. 10: 637-646 https://doi.org/10.1038/sj.gt.3301931
  13. Hageman, G. S., P. J. Luthert, N. H. Victor Chong, L. V. Johnson, D. H. Anderson, and R. F. Mullins. 2001. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20: 705-732 https://doi.org/10.1016/S1350-9462(01)00010-6
  14. Havekes, L., E. de Wit, J. G. Leuven, E. Klasen, G. Utermann, W. Weber, and U. Beisiegel. 1986. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum. Genet. 73: 157-163 https://doi.org/10.1007/BF00291607
  15. Hera, R., M. Keramidas, M. Peoc'h, M. Mouillon, J. P. Romanet, and J. J. Feige. 2005. Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration. Am. J. Ophthalmol. 139: 589-596 https://doi.org/10.1016/j.ajo.2004.11.064
  16. Howes, K. A., J. M. Frederick, A. Marks, and W. Baehr. 2003. Progressive pathways in age-related macular degeneration. Adv. Exp. Med. Biol. 533: 91-96
  17. Kang, K. Y., C. H. Choi, J. Y. Oh, H. Kim, G. R. Kweon, and J. C. Lee. 2005. Chloramphenicol arrests transition of cell cycle and induces apoptotic cell death in myelogenous leukemia cells. J. Microbiol. Biotechnol. 15: 913-918
  18. Kim, S.-J., D. Y. Jun, C. H. Yang, and Y. H. Kim. 2006. Cloning and expression of hpaA gene of Korean strain Helicobacter pylori K51 in oral vaccine delivery vehicle Lactococcus lactis subsp. lactis MG1363. J. Microbiol. Biotechnol. 16: 318-324
  19. Klaver, C. C., M. Kliffen, C. M. van Duijn, A. Hofman, M. Cruts, D. E. Grobbee, C. van Broeckhoven, and P. T. de Jong. 1998. Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet. 63: 200-206 https://doi.org/10.1086/301901
  20. Klein, R., T. Peto, A. Bird, and M. R. Vannewkirk. 2004. The epidemiology of age-related macular degeneration. Am. J. Ophthalmol. 137: 486-495 https://doi.org/10.1016/j.ajo.2003.11.069
  21. Kliffen, M., H. S. Sharma, C. M. Mooy, S. Kerkvliet, and P. T. de Jong. 1997. Increased expression of angiogenic growth factors in age-related maculopathy. Br. J. Ophthalmol. 81: 154-162 https://doi.org/10.1136/bjo.81.2.154
  22. Kliffen, M., E. Lutgens, M. J. Daemen, E. D. de Muinck, C. M. Mooy, and P. T. de Jong. 2000. The APO($^{\ast}$)E3-Leiden mouse as an animal model for basal laminar deposit. Br. J. Ophthalmol. 84: 1415-1419 https://doi.org/10.1136/bjo.84.12.1415
  23. Ko, H.-R., H. Kakeya, A. Yoshida, R. Onose, M. Ueki, M. Muroi, A. Takatsuki, H. Matsuzaki, and H. Osada. 2002. PC- 766B' and PC 766B, 16-membered macrolide angiogenesis inhibitors produced by Nocardia sp. RK-97-56. J. Microbiol. Biotechnol. 12: 829-833
  24. Kopitz, J., F. G. Holz, E. Kaemmerer, and F. Schutt. 2004. Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie 86: 825-831 https://doi.org/10.1016/j.biochi.2004.09.029
  25. Lee, S. J., S. Kadambi, K. C. Yu, C. David, S. Azhar, A. D. Cooper, and S. Y. Choi. 2005. Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase. J. Lipid Res. 46: 27-35 https://doi.org/10.1194/jlr.M400184-JLR200
  26. Lim, J. K., H. J. Seo, E. O. Kim, M. Meydani, and J. D. Kim. 2006. Identification of anti-angiogenic and anti-cell adhesion materials from halophilic enterobacteria of the Trachurus japonicus. J. Microbiol. Biotechnol. 16: 1544-1553
  27. Mahley, R. W., Y. Huang, and S. C. Rall Jr. 1999. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J. Lipid Res. 40: 1933-1949
  28. Malek, G., C. M. Li, C. Guidry, N. E. Medeiros, and C. A. Curcio. 2003. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am. J. Pathol. 162: 413-425 https://doi.org/10.1016/S0002-9440(10)63836-9
  29. Mori, K., E. Duh, P. Gehlbach, A. Ando, K. Takahashi, J. Pearlman, K. Mori, H. S. Yang, D. J. Zack, D. Ettyreddy, D. E. Brough, L. L. Wei, and P. A. Campochiaro. 2001. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J. Cell Physiol. 188: 253-263 https://doi.org/10.1002/jcp.1114
  30. Mori, K., P. Gehlbach, A. Ando, D. McVey, L. Wei, and P. A. Campochiaro. 2002. Regression of ocular neovascularization in response to increased expression of pigment epitheliumderived factor. Invest. Ophthalmol. Vis. Sci. 43: 2428-2434
  31. Mullins, R. F., S. R. Russell, D. H. Anderson, and G. S. Hageman. 2000. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14: 835-846 https://doi.org/10.1096/fasebj.14.7.835
  32. Ogata, N., A. Ando, M. Uyama, and M. Matsumura. 2001. Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefe's Arch. Clin. Exp. Ophthalmol. 239: 87-95 https://doi.org/10.1007/s004170000235
  33. Pola, R., E. Gaetani, A. Flex, T. Aprahamian, A. S. Proia, M. Bosch-Marce, R. C. Smith, and P. Pola. 2003. Peripheral nerve ischemia: Apolipoprotein E deficiency results in impaired functional recovery and reduction of associated intraneural angiogenic response. Exp. Neurol. 184: 264-273 https://doi.org/10.1016/S0014-4886(03)00260-7
  34. Presta, M., P. Dell'Era, S. Mitola, E. Moroni, R. Ronca, and M. Rusnati. 2005. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16: 159-178 https://doi.org/10.1016/j.cytogfr.2005.01.004
  35. Rudolf, M., B. Ivandic, J. Winkler, and U. Schmidt-Erfurth. 2004. Accumulation of lipid particles in Bruch's membrane of LDL receptor knockout mice as a model of age-related macular degeneration. Ophthalmologe 101: 715-719
  36. Schmidt, S., C. Klaver, A. Saunders, E. Postel, M. De La Paz, A. Agarwal, K. Small, N. Udar, J. Ong, M. Chalukya, A. Nesburn, C. Kenney, R. Domurath, M. Hogan, T. Mah, Y. Conley, R. Ferrell, D. Weeks, P. T. de Jong, C. van Duijn, J. Haines, M. Pericak-Vance, and M. Gorin. 2002. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet. 23: 209-223 https://doi.org/10.1076/opge.23.4.209.13883
  37. Scrofani, S. D. B. and A. D. Nash. 2001. Toward a structurefunction relationship for vascular endothelial growth factor- B (VEGF-B). J. Microbiol. Biotechnol. 11: 543-551
  38. Simonelli, F., M. Margaglione, F. Testa, G. Cappucci, M. P. Manitto, R. Brancato, and E. Rinaldi. 2001. Apolipoprotein E polymorphisms in age-related macular degeneration in an Italian population. Ophthalmic Res. 33: 325-328 https://doi.org/10.1159/000055688
  39. Sullivan, P. M., H. Mezdour, S. H. Quarfordt, and N. Maeda. 1998. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe$^{\ast}$2. J. Clin. Invest. 102: 130-135 https://doi.org/10.1172/JCI2673
  40. Weisgraber, K. H., T. L. Innerarity, and R. W. Mahley. 1982. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257: 2518-2521
  41. Werdich, X. Q., G. W. McCollum, V. S. Rajaratnam, and J. S. Penn. 2004. Variable oxygen and retinal VEGF levels: Correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy. Exp. Eye Res. 79: 623-630 https://doi.org/10.1016/j.exer.2004.07.006
  42. Yamamura, T., L. M. Dong, and A. Yamamoto. 1992. Apolipoprotein E polymorphism and coronary heart disease. Chin. Med. J. (Engl) 105: 738-741